Aromasin 25mg (Turkey)
Aromasin 25mg (Turkey)
$47.40
Earn 2 points upon purchasing this product.
30 Tablets
Requires Prescription
SKU: 64639 Categories: Cancer Drugs, Exemestane, Family Planning, Generic, India, Prescription Drugs, Reproductive HealthUses of Aromasin
Aromasin is a prescription medicine used to treat breast cancer in postmenopausal women. It is specifically used for early breast cancer – which means the condition is only in your breast.
It is also given to women who have already been diagnosed with advanced breast cancer – a condition that has already spread to other parts of the body.
Aromasin works by lowering estrogen levels in postmenopausal women. This process eventually slows the growth of breast tumors. Aromasin is available under the generic name Exemestane.
Aromasin Precautions and Warnings
Do not use Aromasin if you are allergic to it. This medicine is not allowed for women who have not started menopause and those who plan to get pregnant.
To ensure Aromasin is safe to use, tell your healthcare professional if you have a history of the following conditions:
- Liver disease
- Kidney problems
If you are still having your monthly period, this medicine may not be good for you. If you are pregnant, Aromasin can potentially harm your unborn baby, so avoid taking it.
Aromasin Dosage
Take 25 mg of Aromasin orally once per day. The recommended dosage for this medicine is only one tablet for daily consumption. Aromasin is usually taken after a meal. Taking this medicine at the same time each day is highly advisable.
Aromasin Side Effects
Common side effects:
- Headache
- Tiredness
- Joint pain
- Nausea
- Vomiting
- Insomnia
- Sweating
- Shortness of breath
- Bone pain
- Chest pain
Only logged in customers who have purchased this product may leave a review.
Cart
Product Search
Product Categories
Top Rated Products
-
Arpizole 15mg
$39.26
-
Altace 2.5mg
$67.51
-
Atrovent Inhaler 20mcg
$39.34
-
Cobix 100mg (India)
$39.99
-
Escitalopram 10mg
$28.59
-
Kreon 150mg (Turkey)
$44.15
Reviews
There are no reviews yet.